Richard A. Miller M.D., President and CEO at Corvus Pharmaceuticals, Inc. (CRVS), bought 25,000 shares at $0.76 ($19K) on 2022-09-28, disclosed to the SEC on 2022-09-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| CRVS | BUY | 2022-12-15 | $45K | — | Filing → |
| CRVS | BUY | 2022-09-20 | $16K | — | Filing → |
| CRVS | BUY | 2022-06-28 | $10K | — | Filing → |